Discovering a passion for entrepreneurship (and taking the leap to launch a business)
Dr. Marc Myer, EMBA '19, is CEO and Cofounder of Hyperion Health Inc. in Minneapolis, MN.
Dr. Marc Myer, EMBA '19, is CEO and Cofounder of Hyperion Health Inc. in Minneapolis, MN.
Inspired by the struggles of other pet owners, Ellen Herzfelder, SM ’87, co-founded BetterVet, a healthcare tech startup that leverages telemedicine and at-home doctor visits to provide pets and their owners with safe and convenient access to veterinary care.
The MIT Sloan MBA Class of 2020 persevered despite a global pandemic, an increasingly difficult job market, and many other ongoing challenges. New graduates like Carolina Goncebat, MBA ’20, have since succeeded in making their mark in numerous industries across the globe.
Guadalupe Hayes-Mota, SB ’08, LGO ’16, is one of eight recipients of this year's Margaret L. A. MacVicar, SB ’65, ScD ’67, Award, which is given in recognition of one’s innovation at, dedication to, and impact on the MIT Alumni Association or the Institute in any area of volunteer activity.
MIT Media Lab's Rosalind Picard will be a guest at "Live do Valor," hosted by Valor Econômico editor João Luiz Rosa, to discuss new developments in artificial intelligence applied to the healthcare industry.
Imagine diagnosing a disease before symptoms begin. Or diagnosing cancer without a biopsy. The proteins in our blood could be the key to making these things possible.
BARRON'S | Kristin Forbes, Jerome and Dorothy Lemelson Professor of Management and Global Economics at MIT Sloan, does the math on Jerome Powell's tenure.
Our collaboration with Senator John Hickenlooper’s office on the BIG WIRES Act exemplifies exactly what we’re here to do.
PROJECT SYNDICATE | MIT’s Simon Johnson sat down with fellow Nobel laureate economist Philippe Aghion to examine what ails Europe and how to revive its dynamism. Their conversation addresses the costs of excessive regulation, the role of creative destruction in fostering competition, and the case fo...
A Financial Public Private Partnership to Cure Rare Diseases